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Abbreviations and acronyms  
Ahr  aryl hydrocarbon receptor 
ANOVA analysis of variance 
CCL-2  chemokine (C-C motif) ligand 2 
CON  control diet  
CVD  cardiovascular disease 
FVOO  functional virgin olive oil enriched with its own phenolic compounds 
FVOOT functional virgin olive oil enriched with phenolic compounds from olive oil 
and thyme 




MAPK mitogen-activated protein kinases  
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OO  olive oil 
OO-PC olive oil phenolic compounds 
PC  phenolic compounds 
PON  paraoxonase 
Ppar  peroxisome proliferator-activated receptor 
SEC  control diet supplemented with OO-PC extract, mainly secoiridoids or 
hydroxytyrosol derivatives 
SEC+THY diet supplemented with secoiridoids and thyme phenols extracts 
Th-PC  phenolic compounds from thyme 
THY  diet supplemented with thyme phenols extract 
TPC  total phenol content 
VOO  virgin olive oil 
 
 
Keywords: flavonoids, olive oil, phenolic compounds, PON, secoiridoids. 
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Scope: Low paraoxonase (PON)1 activities, and high PON1 and low PON3 protein levels are 
characteristic of cardiovascular disease. Our aim was to assess short and long-term effects of 
virgin olive oils (VOO), enriched with their own phenolic compounds (PC; FVOO) or with 
them plus complementary PC from thyme (FVOOT), on PON-related variables and the 
mechanisms involved.  
Methods and results: Two randomized, controlled, double-blind, and crossover 
interventions were conducted. In an acute intake study, participants ingested three FVOOs 
differing in PC content. In a sustained intake study, participants ingested a control VOO and 
two different FVOOs with the same PC content but differing in PC source. Acute and 
sustained intake of VOO and FVOO decreased PON1 protein and increased PON1-associated 
specific activities, while FVOOT yielded opposite results. PON3 protein levels increased 
only after sustained consumption of VOO. Mechanistic studies performed in rat livers 
showed that intake of isolated PC from VOO and from thyme modulate mitogen-activated 
protein kinases and peroxisome proliferator-activated receptors regulating PON synthesis, 
while a combination of these PCs cancels such regulation. 
Conclusion: The present study reveals that the intake of phenol-enriched FVOOs modulates 
oxidative balance by modifying PON-related variables according to PC content and source, 
and this modulation can be perceived as beneficial.  
 
 
Two randomized, controlled, double-blind, and crossover interventions were conducted: 
Acute study: intake of functional virgin olive oils (FVOO) differing in phenolic compounds 
(PC) content; Sustained study: intake of different FVOOs (same PC content but different 
source). Main outcomes include that the acute and sustained consumption of olive oil-PC in 
humans modifies PON-related variables towards a beneficial mode, increasing PON1 protein 
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and decreasing its specific activities and PON3 protein. A combination of olive oil and thyme 
PC cancels such regulation.  
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1. Introduction  
The paraoxonase (PON) enzyme family comprises of three members (PON1-3). In humans, 
PON1 and PON3 are expressed mainly in the liver and kidney, and to a lesser extent in other 
organs such as brain, colon, heart, kidney, lung and small intestine. They both are secreted 
into the blood where they associate with apolipoprotein (Apo)A-I-containing high-density 
lipoprotein (HDL) [1–3]. PON2 is exclusively intracellular and it is expressed in nearly all 
human tissues, though it is not found in circulation [4, 5]. All PON enzymes have lactonase 
activity, and PON1 can also hydrolyze aromatic esters and certain organophosphate 
compounds, such as paraoxon, having arylesterase and paraoxonase activities [2]. PON1 and 
PON3 exert beneficial effects on cardiovascular disease (CVD) by preventing lipoprotein 
oxidation, metabolizing lipid peroxides, promoting cholesterol efflux to HDL, and showing 
anti-inflammatory activity via inhibition of chemokine (C-C motif) ligand 2 (CCL-2) [2, 6–
9]. PON1 and PON3 proteins, together with PON1-associated activities, play a crucial role in 
CVD and other related conditions, since decreased PON3 mass, increased PON1 mass, and 
decreased PON1-associated activities have been related to an increase in plaque formation 
and to high CVD risk [5, 7, 10–13].  
Phenolic compounds (PC), naturally present in fruit and vegetables, modulate hepatic PON1 
gene expression as well as hepatic and plasma activities in mice [14–16] and humans [17, 
18]. In particular, hydroxytyrosol from olive oil (OO) and flavonoids from several sources 
have been extensively described as triggering PON1 activities in animals [15, 19, 20] and 
humans [18, 21, 22]. In 2011 the European Food Safety Authority (EFSA) released a claim 
concerning the effects of a daily intake of 5 mg of the PC hydroxytyrosol (a simple phenolic 
compound) and its derivatives on low-density lipoprotein (LDL) protection from oxidation 
[23]. Nevertheless, the phenolic content in most virgin OOs (VOO) available on the market 
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are low to allow the recommended consumption of hydroxytyrosol and its derivatives within 
the context of a balanced diet [23]. The enrichment of VOO with its own PC, or with 
complementary PC from other sources, has been postulated as an interesting strategy to 
increase the daily PC intake without increasing caloric intake [24, 25]. Thyme (Thymus 
zyguis) is the herb selected in this study for VOO flavoring, as it is one of the richest sources 
of flavonoids [26]. Our previous studies have reported that PC from thyme (Th-PC) enhances 
the bioavailability of the PC from OO (OO-PC) [27, 28], and that a thyme-enriched OO 
intervention improves HDL oxidative status [29] and DNA protection against oxidation [30], 
and exerts a cardioprotective impact on HDL particles [31–33]. However, the prospective 
beneficial properties of these phenol-enriched VOOs on PON enzymes remain unknown. 
Furthermore, most of the studies assessing PON concentrations and activities have been 
undertaken after sustained interventions and thus only long-term modifications have been 
studied. As HDL turnover is considerable, it seems safe to predict that PON enzymes might 
also undergo short-term modifications. As a result, postprandial studies are needed to obtain 
further insights regarding PC effects on PON family. Additionally, no data concerning the 
transcriptional effects of OO-PC on PON1 have been published to date, as most mechanistic 
studies are focused on PON1 regulation carried out by drugs or flavonoids [1–3, 34]. 
Our hypothesis is that the consumption of OO-PC may modulate PON-related variables (i.e. 
PON1 and PON3 protein levels along with PON-1 lactonase and paraoxonase activities) 
towards a beneficial mode, and that blending OO-PC with complementary Th-PC, might 
instigate synergic effects. The aim of the present work was to assess the short and long-term 
effects of the acute and sustained intake of different VOOs, enriched with OO-PC or with 
them plus complementary Th-PC, on PON-related variables. A secondary objective was to 
investigate the mechanisms involved in the OO-PC and Th-PC effects on such variables. 
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2. Materials and methods 
2.1 Phenol-enriched OO preparation and composition 
Different set of VOOs were prepared for each of the 2 interventions. For the acute study, 
three VOOs enriched with their own PC, but differing in their total phenolic content were 
prepared as previously described [24]: Low-functional VOO (L-FVOO: 250 ppm), Medium-
functional VOO (M-FVOO: 500 ppm) and High-functional VOO (H-FVOO: 750 ppm). A 
VOO (80 ppm) was used as the matrix to prepare these phenol-enriched VOOs by adding a 
freeze-dried olive cake extract rich in the main OO-PC, mainly secoiridoids or oleuropein 
derivatives as the main source of hydroxytyrosol [35]. Regarding the sustained intake study, 
the same parental VOO used for the acute study was used as a control condition and as a 
matrix to prepare two functional VOOs, enriched with equal content of PC (500 ppm) but 
differing in the PC source. The first one was enriched with its own PCs (FVOO) while the 
second one (FVOOT) was enriched with its own PC (50%; mainly secoiridoid derivatives) 
plus complementary PC from thyme (50%; mainly flavonoids, phenolic acids, and 
monoterpenes) [26]. These three VOOs did not differ in fatty acid and micronutrient 
composition other than the phenolic content [29, 31]. The phenolic composition of the VOOs 
used in both studies was quantified by UPLC-MS/MS following the chromatographic method 
described previously [27]. The phenolic intake through the ingested dose of the VOOs used 
in the acute (30 mL) and sustained study (25 mL) is shown in Supporting Information Table 
S1. 
2.2 Designs of the studies and participants’ characteristics 
Both studies were randomized, controlled, double-blind and crossover trials. In the acute 
study the short-term effects of VOO with different PC content on PON-related variables were 
determined. In the sustained study the long-term effects of phenol-enriched VOOs, with the 
same PC content but with PC from different sources, on PON-related variables were 
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determined. As depicted in Figure 1A, the acute study was carried out in 12 participants, 
considered healthy according to a physical examination and routine laboratory tests. 
Participants were instructed to follow a stabilization diet for 2 weeks before the first 
intervention and 1-week washout periods between each VOO intervention in order to avoid 
potential carry-over effect. In the interventions, participants ingested a single dose of 30 mL 
of raw VOO (L-FVOO, M-FVOO or H-FVOO). Fasting blood samples were collected at 
baseline and at different postprandial times (2h, 4h and 6h). The sustained study (Figure 1B) 
was conducted in 33 hypercholesterolemic subjects (total cholesterol>200 mg/dL). 
Participants ingested a daily dose of 25 mL of raw OO for 3 weeks, accordingly with the 
assigned sequence of intervention, preceded by 2-week washout periods with a common OO. 
To avoid an excessive intake of antioxidants during the clinical trial period, participants were 
instructed to limit the consumption of PC-rich foods. Blood samples were collected at the 
beginning and at the ending of each intervention, and sera and plasma EDTA samples were 
stored at -80ºC until their use. Glucose and lipid profile were measured in plasma EDTA, in a 
Cobas-Mira Plus (Roche Diagnostic System, Spain) and ApoA-I, ApoA-II, and ApoB-100 in 
a PENTRA-400 (ABX-Horiba Diagnostics, France) automated analyzers. The details of the 
participants and the protocol of both studies have been previously described [29, 33]. The 
present clinical trials were conducted in accordance with the Helsinki Declaration and the 
Good Clinical Practice for Trials on Medical Products in the European Community and 
International Conference of Harmonization. The subjects gave their written informed consent 
before their participation. Acute study was registered at ClinicalTrials.gov (Identifier: 
NCT01347515). Sustained study was registered at the International Standard Randomized 
Controlled Trial register (Identifier: ISRCTN77500181).  
2.3 Experimental procedures with rats 
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To add insights to the underlying mechanisms involved in PON modulation, 20 male and 
female Wistar rats (Charles River Laboratories; Spain) weighing 300-350g were allocated to 
four groups: CON, control diet; SEC, control diet supplemented with OO-PC extract, mainly 
secoiridoids or hydroxytyrosol derivatives; THY, diet supplemented with Th-PC extract; and 
SEC+THY, diet supplemented with secoiridoids and Th-PC extracts. Extracts were prepared 
as previously described [35]. SEC and SEC+THY extracts correspond to the ones used for 
FVOO and FVOOT preparation, respectively. Rats ingested 5 mg of the appropriate phenolic 
extract/kg rat/day for 21 days. As the matrix employed in the four groups was the same, i.e. 
the commercial feed pellets Teklad Global 14% Protein Rodent Maintenance Diet (Harlan 
Laboratories, Santa Perpètua de Mogoda, Spain), the effects observed between groups may 
be entirely attributed to their different phenolic content. The dose selected was extrapolated 
to human dose through normalization to body surface area [36]. THY group was used to 
investigate the effect of an equivalent phenolic dose exclusively from thyme. Details of the 
diets and dosage administered are explained in Supporting Information Table S2. Rats were 
anesthetized with isoflurane (IsoFlo, Veterinarian Esteve, Italy) and sacrificed by intracardiac 
puncture. After blood collection, rats were perfused with an isotonic solution of sodium 
chloride 0.9% to remove the remaining blood irrigating the tissues, and their livers were 
excised. Sera samples were obtained and stored at -80ºC until their use. The procedures were 
conducted in accordance with the guidelines of the European Communities Directive 
86/609/EEC regulating animal research and approved by the local ethical committee (CEEA-
Universitat de Lleida, reference 7675).  Glucose and lipid profile were measured in an 
autoanalyzer Cobas-Mira Plus (Roche Diagnostic System, Spain). 
2.4 PON3 and PON1 protein concentration 
PON3 and PON1 protein concentrations were assessed in human sera by in-house ELISA 
with rabbit polyclonal antibodies generated against synthetic peptides with sequences specific 
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for mature PONs (kindly provided by Dr. Mackness, Manchester University, UK) as 
previously described [37].  
2.5 Paraoxonase and lactonase activities 
Since PON1 has esterase and lactonase activities we decided to measure the catalytic activity 
of PON1 using two different substrates: paraoxon (an ester) and 5-thiobutyl butyrolactone 
(TBBL, a synthetic lactone). Both activities were assessed in human sera as previously 
described [38, 39]. These activities are expressed as U/L (1U=1μmol of substrate hydrolyzed 
per minute), and are referred as raw activities throughout this work. Specific activities were 
calculated as the ratio between the activity and the corresponding concentration. 
2.6 Kinases array 
A kinases proteome profiler (R&D systems, USA) was used in rat liver homogenates to 
assess the activation of not only the three major families of Mitogen-Activated Protein 
Kinases (MAPK; ERK1/2, JNK1-3 and p38α/β/δ/γ) but also other related kinases that play an 
important role in cellular signaling pathways. 125 mg of hepatic tissue were lysed using a 
commercial lysis buffer (Cayman Chemical, USA) containing DTT and proteases and 
phosphatases inhibitors. Finally, 200μg of total protein assessed with Bradford assay, were 
employed to perform the array. Chemiluminescence signal was measured in Amersham 
Imager 600 reader and data were acquired using Image Quant TL program (GE Healthcare, 
Spain). CON values were set at 1 and SEC, THY and SEC+THY results are expressed as 
fold-increase or -decrease vs. CON values. 
2.7 Real-Time Quantitative PCR 
Gene expression of Pon1, Pon3, Ccl-2, aryl hydrocarbon receptor (Ahr), peroxisome 
proliferator-activated (Ppar)α, δ and γ were analyzed in rat liver homogenates. 30 mg of 
hepatic tissue were homogenized and lysed with a rotor-stator DIAX 900 homogenizer 
(Heidolph, Germany). Total RNA was purified, quantified and reverse transcribed to cDNA 
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as previously described [40]. Real-time quantitative PCR was performed in ABI PRISM® 
7900HT Sequence Detection System (Applied Biosystems, USA). Data were analyzed using 
the 2
−ΔΔCt
 method with glyceraldehyde 3-phosphate dehydrogenase as housekeeping gene. 
CON values were set at 1 and SEC, THY and SEC+THY results are expressed as fold-
increase or -decrease vs. CON values. 
2.8 Sample size and power analysis 
In the acute study, a sample size of 12 individuals allows a power of at least 80% to detect a 
statistically significant difference between groups of 1.7 mg/dL of HDL cholesterol (HDL-C) 
and a SD of 1.9. In the sustained study, a sample size of 30 individuals allows a power of at 
least 80% power to detect a statistically significant difference between groups of 3 mg/dL of 
HDL-C and a SD of 1.9. In both cases, a dropout rate of 15% and a Type I error of 0.05 (2-
sided) were assumed.  
2.9 Statistical Analyses 
Kruskal-Wallis test or 1-factor analysis of variance (ANOVA) with Bonferroni correction 
was used to discard differences in baseline characteristics. Carryover effect was discarded by 
testing a period-by-treatment interaction term in general linear models. A general linear 
model for repeated measures was used to assess the OOs effects within and between 
interventions (intra- and inter-intervention differences, respectively). In the animal studies, 
ANOVA with Bonferroni correction was used to assess the effects of the phenolic extracts. 
Pearson correlations were calculated between the variables described in results section. 
Statistical significance was defined as p<0.05 for a 2-sided test. Analyses were performed 
using SPSS for Windows, version 22 (IBM corp., USA).   
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3.1 Characteristics of the study participants 
For the acute study 13 participants were recruited, and 12 were eligible and completed the 
study. For the sustained study, 62 participants were recruited and 33 were eligible to be 
enrolled in the study. No adverse events related to OO intake were reported. Baseline 
characteristics of acute and sustained study participants are described in Supporting 
Information Tables S3 and S4, respectively. No statistical differences were found between 
treatment sequences. 
3.2 Acute study 
3.2.1 PON3 and PON1 protein levels 
All OO tested showed a similar time-course trend for PON3 characterized by a decrease at 
4h-time point (4.2-11%; p<0.05; Figure 2A) vs. their baseline. No statistical differences were 
observed among the functional VOOs tested at any time point. Regarding PON1 (Figure 2B), 
L-FVOO and M-FVOO decreased this protein after 2h of OO intake (5.1-6.4%; p<0.05), 
while H-FVOO promoted a trend to increase PON1 at this time point vs. baseline (6.8%), 
although without statistical significance. These different time-course trends were statistically 
significant at 2h when comparing L-FVOO and M-FVOO with H-FVOO (p<0.05). Detailed 
data of PON1-3 proteins are shown in Supporting Information Tables S5 and S6. 
3.2.2 PON1 lactonase and paraoxonase activities 
After all the functional VOOs tested, lactonase raw activity peaked at 2h-time point (3.3-
7.1%) and then reached a steady state at 4h (Figure 2C). Inter-interventions changes were 
observed at 4h- and 6h-time points between H-FVOO and the other two functional VOO 
(p<0.05). Concerning paraoxonase raw activity, L-FVOO and M-FVOO intake prompted a 
mild increase at 2h-time point followed by a decrease at 4h-time point (p<0.05). In contrast, 
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H-FVOO triggered a steady drop throughout the time-frame assessed (p<0.05). Nevertheless, 
no inter-interventions changes were observed in the paraoxonase kinetics at any time point 
(Figure 2D). Regarding lactonase and paraoxonase specific activities, both peaked 2h after L-
FVOO and M-FVOO intake, dropping to basal values at 4h-time point (Figures 2E-F; 
p<0.05). H-FVOO consumption followed different kinetic trend, as no peak was observed. 
When inter-intervention differences were addressed, H-FVOO showed lower paraoxonase 
and lactonase specific activities at 2h when compared with L-FVOO and M-FVOO, 
respectively (p<0.05). Detailed data of PON1-associated activities are shown in Supporting 
Information Tables S5 and S6.  
3.3 Sustained study 
3.3.1 PON3 and PON1 protein levels 
PON3 levels increased by 5.1% after VOO intervention (p<0.05; Figure 3A). This increase 
was significant when compared with the changes observed after FVOO and FVOOT 
interventions (p<0.05). PON1 levels decreased by 10.9-12.4% after VOO and FVOO 
respectively, whilst increased by 4.04% after FVOOT (p<0.05; Figure 3B). This increase 
turned out to be statistically significant when compared with the changes observed after VOO 
and FVOO interventions (p<0.05).  
3.3.2 PON1 lactonase and paraoxonase activities 
FVOO decreased lactonase raw activity (3.39%; p<0.05; Figure 3C), which turned out to be 
significant when compared with VOO and FVOOT interventions. VOO increased and 
FVOOT decreased paraoxonase raw activity (p<0.05; Figure 3D). These changes were 
statistically different when compared with FVOO intervention (p<0.05). VOO and FVOO 
increased lactonase and paraoxonase specific activities to similar extent (8.1%-12%) whereas 
FVOOT promoted a trend to decrease these activities (9.3 and 13.7% respectively) although 
without statistical significance (Figures 3E-F). These decreases observed after FVOOT were 
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statistically different when compared with the increases observed after VOO and FVOO 
intake (p<0.05). Comprehensive data of PON levels obtained in the chronic study is shown in 
Supporting Information Table S7. After all OO tested, strong positive correlations were 
observed between the activities assessed (p<0.05; Supporting Information Table S8) but no 
between activities and PON1-3 proteins (data not shown). In addition, after VOO intake, 
paraoxonase specific activity directly correlated with ApoA-I determined in HDL and in 
plasma EDTA (r=0.529 p=0.003; r=0.481 p=0.007 respectively). Paraoxonase specific 
activity and ApoA-I also correlated positively after FVOO and FVOOT intake, but such 
correlations were weaker and statistically non-significant. 
3.4 Mechanistic study: Animal model 
 3.4.1 Glucose and plasma lipid profile 
No statistical differences were found between treatment groups (CON, SEC, THY and 
THY+SEC) at the end of the interventions (Supporting Information Table S9). 
3.4.2 Kinases activation 
MAPK activation was assessed in rat hepatic tissue, as several transcription factors regulated 
by this kinase family modulate PON1 expression in human hepatic cells [41, 42] and rat liver 
homogenates [43]. Activation of the vast majority of MAPK was observed after diet 
supplementation with SEC and THY extracts when compared with control diet (CON; 
p<0.05; Figure 4A). Diet supplementation with SEC+THY abolished ERK1, JNK2, JNK-
PAN and p38β activation observed after SEC and THY intake (p<0.05). Kinases, other than 
MAPK, activation was also assessed (Figure 4B).  
SEC and THY intake increased almost all these kinases activation to the same extent 
(p<0.05), except for p53 that was activated only by THY. SEC+THY intake activated 
(MKK6, MSK2, Akt pan) and inhibited (p53) some kinases compared with CON (p<0.05). 
This regulation resulted statistically significant also compared to SEC and THY (MKK3, 
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RSK1 and GSK-3α/β; p<0.05). Other kinases with no statistical changes were studied 
(HSP27, Akt1, Akt3, CREB, GSK-3β and TOR; data not shown). 
3.4.3 Transcription factors gene expression 
SEC and THY diet supplementation decreased Pparα to the same extent compared to CON 
(p<0.05), showing a tendency to increase Pparδ and Pparγ. No effects were observed after 
SEC+THY in any Ppar studied (Figure 5A). No changes were observed on Ahr gene 
expression in response to the intake of any of the extracts studied (data not shown). However, 
Ahr gene expression positively correlated with Pparδ in SEC and had a tendency to correlate 
with Pon1 in CON (r=0.953; p=0.047 and r=0.840; p=0.075, respectively; Supporting 
Information Table S10). 
3.4.4 Pon1, Pon3 and Ccl-2 gene expression 
SEC intake increased Pon3 hepatic gene expression and had a tendency to increase Pon1 vs. 
CON group (p<0.05), while THY intake decreased Pon1 and Pon3 vs. SEC group (p<0.05; 
Figure 5B). Pon1 gene expression correlated with Pparγ (r=0.966; p=0.034) and had a 
tendency to correlate with Pparα (r=0.932; p=0.068) in SEC group (Supporting Information 
Table S10). No statistical differences were shown in Ccl-2 gene expression, surely due to the 
high inter-individual variability (data not shown).  
4. Discussion 
The present work confirms the hypothesis that the acute and sustained intake of phenol-
enriched VOOs modulates PON-related variables according to PC source and content. On the 
one hand, after the acute and sustained intake of OO-PC (via VOO and FVOO intake) a 
decrease in PON1 protein, together with increases in PON3 protein levels and PON1-
associated specific activities are reported. On the other hand, sustained intake of a mixture of 
OO-PC and Th-PC (via FVOOT intake) induces opposite results rather than producing 
synergic effects as we had hypothesized. These differences may be due to the combination of 
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OO-PC with Th-PC intake, rather than the sole presence of Th-PC, since mechanistic studies 
revealed that single-type PC modulated PON synthesis, while no effects were observed when 
PC were combined. To the best of our knowledge, this is the first time that a human trial has 
been conducted to integrate the short and long-term effects of PC consumption on PON-
related variables.  
In the human acute study, the time-course trend for PON1 protein and associated specific 
activities turn out to be different according to the content of OO-PC of the FVOO consumed. 
PON1 protein reached minimum and specific activities peaked 2h after L-FVOO and M-
FVOO intake while different kinetics were observed with H-FVOO. Such observations are 
supported by the bioavailability of the OO-PC themselves, as OO-PC undergo a rapid 
absorption with Tmax around 1–2h after ingestion, and plasma concentrations return to 
baseline values 6h after ingestion [24]. Actually, the selection of M-FVOO for the sustained-
intake study was made according to previous works developed by our group. On the one 
hand, a pharmacokinetic study revealed that plasmatic phenolic metabolites did not show a 
complete linear response after 500 ppm and 750 ppm, indicating that a threshold could exist 
in OO phenolic absorption [24]. On the other hand, M-FVOO provided additional benefits in 
the endothelial function versus L-FVOO and H-FVOO, and showed a better postprandial 
response on several cardiovascular risk biomarkers [44]. 
In the sustained intake study, the present work shows that VOO and FVOO intake equally 
decreased PON1 protein and increased PON1-associated specific activities, irrespective of 
OO-PC content. Increased PON1 protein levels and decreased activities are characteristic of 
diseases whose underlying mechanisms comprise an impairment of oxidative stress, in 
particular CVD [10, 11, 45, 46], diabetes mellitus [47], inflammatory diseases [48, 49], 
cancer, and several hepatic and renal diseases [50, 51], all characterized by having 
dysfunctional HDL particles and increased CVD risk [2]. Furthermore, PON1 activities 
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positively correlate with the improvement of HDL antioxidant properties, to such an extent 
that PON1 activities have been proposed as new biomarkers of HDL function and CVD risk 
[10, 52]. Therefore, the decrease in PON1 protein and the increase in its associated activities 
can be perceived as being beneficial as they might be indicative of a proper oxidative balance 
and therefore of HDL function enhancement. 
The combination of OO-PC with Th-PC via FVOOT yielded opposite effects than those 
observed after OO-PC intake, as FVOOT increased PON1 protein and decreased its 
associated specific activities. Hence, beneficial effects observed after OO-PC may be due to 
the secoiridoids (the main phenolic compounds of VOOs) irrespective of their content, and 
these effects may be reversed by Th-PC, mainly flavonoids. Our previous studies have 
reported that flavonoids present in FVOOT enhance cardioprotective benefits [29–33]. 
Similarly, pomegranate juice rich in flavonoids and phenolic acids, and extra-VOO enriched 
with green tea flavonoids, increase arylesterase activity in ApoE-deficient mice [16, 20] and 
humans [18]. Red wine flavonoids and stilbenes trigger paraoxonase activity in 
hypercholesterolemic hamsters [19]. The dissimilarities between the results obtained in the 
present work and those from other authors could be attributed to the combination of Th-PC 
with OO-PC, rather than the sole presence of flavonoids, as discussed further on.  
PON3 protein levels increased after the sustained intake of control VOO suggesting that such 
VOO plays a protective role, as PON3 depletion from HDL is associated with the presence of 
subclinical atherosclerosis in patients with autoimmune diseases [7], chronic hepatitis, and 
liver cirrhosis [53]. Our results partially agree with those observed in a proteomic study 
carried out in the HDL from the VOHF participants, where an increase in PON3 protein was 
reported after the sustained intake of VOO, FVOO, and FVOOT [33].  
The effects observed in PON-related variables in the present work can be translated in an 
enhancement of HDL functionally. Within the frame of the VOHF study, an improvement in 
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HDL functionality, particularly in the HDL-mediated cholesterol efflux has been observed 
following phenol-enriched VOOs consumption (submitted data). Additional effects related to 
the enhancement of HDL function after phenol-enriched VOOs have already been published 
by our group such as improvement of oxidative status [29],  DNA protection against 
oxidation [30], changes in HDL size and distribution [31], and changes in HDL proteome 
[33]. Moreover, PON1 activities have been proposed as promising biomarkers of HDL 
function and CVD risk [10, 52]. Therefore, the increase in PON1-associated activities 
observed after the intake of phenol-enriched VOO may be indicative of HDL functionality 
enhancement. 
In the present work, mechanistic studies were conducted in rat liver homogenates to provide 
insight into the intracellular pathways involved in hepatic PON synthesis modulation [1–3, 
34] and to disclose whether the effects observed after FVOOT were due to the Th-PC per se 
or to their combination with OO-PC. To date, this is the first time that p38 MAPK family and 
MAPK-related kinase effects on PON family are reported. The intake of a single-type PC 
(SEC or THY groups) activated the three families of MAPKs and a vast majority of MAPK-
related proteins, decreased Pparα, and showed a tendency to increase Pparδ and Pparγ to the 
same extent, as similarly described by our group in human white blood cells [54]. 
Interestingly, these effects were not observed after the combination of PC (SEC+THY 
group). However, a minor impact on PON gene expression was observed. Despite showing 
equal effects on Ppars and kinases activation, SEC increased Pon3 and showed a tendency to 
increase Pon1 expression while THY decreased both Pon1 and Pon3. Moreover, Pon1 
directly correlated with Pparγ and Pparα in the SEC group. This suggests that hepatic PON1 
regulation may be mediated via PPARγ, which in turn is mediated via ERK1/2 activation, as 
previously described in glitazones, statins, and pomegranate juice [34, 53, 54]. In 
concordance, our group has previously reported that SEC down-regulates Nuclear Factor-ƙB 
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activation, a transcription factor that is inhibited by PPARγ [30]. THY decreased hepatic 
PON1 and PON3 expression compared to SEC, despite showing equal effects on PPAR, 
MAPK and MAPK-related proteins. These data suggest that Th-PC modulates PON hepatic 
synthesis by means of intracellular pathways other than the PPAR family. The combination 
of OO-PC with Th-PC had no impact on PON hepatic synthesis, in concordance with the lack 
of effects on kinases and PPARs activation observed in the current study. In general terms 
single-type PC, but not their combination, modulated intracellular pathways that regulate 
hepatic PON synthesis. These results help us to understand those obtained in the human 
studies. That is, the combination of OO-PC and Th-PC, rather than the sole intake of Th-PC, 
is accountable for the effects on PON-related variables.  
Several factors other than PON hepatic synthesis regulation might explain the PC effects 
observed in the human studies. Those include hepatic PON1 degradation and secretion to the 
extracellular space [43], PON1 binding to HDL and activation by ApoA-I [3, 50, 57], and 
PON1 redistribution to large and mature HDL [47, 58]. Concordantly, we have previously 
reported that FVOO decreases the small-HDL/large-HDL ratio, increases HDL particle size 
[31], and increases CETP activity [29], all of them indicative of an enhancement of HDL 
maturation. Additionally, the EUROLIVE study showed that the presence of PC metabolites 
in HDL subsequent to the sustained intake of OO-PC-enriched VOOs was accompanied by 
the increase of HDL2 and the decrease in HDL3 particles [59].  
Taking the previously data into consideration, the present work provides first level evidence 
of the modulation of PON enzymes family following the acute and sustained intake of PC-
enriched VOOs, according to PC source and content. Several mechanisms may be involved in 
PON enzymes family modulation, such as the activation of hepatic MAPK and Ppars among 
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others. The changes in PON enzymes family observed may be translated into an improvement 
in the oxidative balance and therefore in the HDL functionality. 
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Figure 1. Human studies design. A) In the acute study the short-term effects of phenol-
enriched VOOs differing in their PC content were assessed: L-FVOO with a low total phenol 
content (TPC; 250 ppm), M-FVOO with a medium TPC (500 ppm) and H-FVOO with a high 
TPC (750 ppm). B) In the sustained study the long-term effects of phenol-enriched VOOs 
differing in its composition were assessed: control VOO (80 ppm); FVOO, enriched with 
OO-PC (500 ppm); FVOOT, combining OO-PC (250 ppm; 50%) and Th-PC (250 ppm; 
50%). PON1 and PON3 protein levels, and lactonase and paraoxonase activities were 
measured at the specified time-points. 
www.mnf-journal.com Page 31 Molecular Nutrition & Food Research 
 




www.mnf-journal.com Page 32 Molecular Nutrition & Food Research 
 
This article is protected by copyright. All rights reserved. 
32 
 
Figure 2. PON kinetics observed in the acute intake study. Participants ingested 30 mL of a 
phenol-enriched VOO differing in their PC content (L-FVOO with a low TPC, 250 ppm; M-
FVOO with a medium TPC, 500 ppm; H-FVOO with a high TPC, 750 ppm). PON-related 
variables were assessed at different postprandial times. A) PON3 protein, B) PON1 protein, 
C) Lactonase raw activity, D) Paraoxonase raw activity, E) Lactonase specific activity, F) 
Paraoxonase specific activity. Results are expressed as mean ± SEM. p<0.05 vs. *L-FVOO; 
vs. †M-FVOO; vs. ‡H-FVOO. 
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Figure 3. Changes in PON-related variables observed in the sustained study. Participants 
ingested 25 mL (22g) of raw OO/day for 3 weeks: control VOO (80 ppm); FVOO enriched 
with its own PCs (500 ppm) or FVOOT enriched with the same content of PC but differing in 
their source (500 ppm; 50% OO-PC and 50% Th-PC). PON-related variables were assessed 
in serum samples at baseline and at the end of each intervention: A) PON3 protein, B) PON1 
protein, C) Lactonase raw activity, D) Paraoxonase raw activity, E) Lactonase specific 
activity, F) Paraoxonase specific activity. Results are expressed as mean ± SEM. *p<0.05 vs. 
baseline; †p<0.05 between interventions. 
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Figure 4. PC effects on A) MAPK and B) MAPK-related kinases activation measured in rat 
hepatic tissue. Rats ingested 5 mg of the appropriate phenolic extract/kg rat/day for 21 days 
and at the end of the study rats were anesthetized with isoflurane and sacrificed by 
intracardiac puncture. After blood collection, rats were perfused with an isotonic solution of 
sodium chloride 0.9% to remove the remaining blood irrigating the tissues, and their livers 
were excised. Hepatic tissue was then lysed and kinases activation were assessed in this 
tissue. Other kinases with no statistical changes were studied (HSP27, Akt1, Akt3, CREB, 
GSK-3β, and TOR; data not shown). CON values were set at 1 and SEC, THY and 
SEC+THY results are expressed as fold-increase or -decrease vs. CON values. *p<0.05 vs. 
control; †p<0.05 vs. SEC; ‡p<0.05 vs. THY. 
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Figure 5. PC effects on gene expression in rat hepatic tissue. A) Pparα, Parδ, and Pparγ; B) 
Pon3 and Pon1. Rats ingested 5 mg of the appropriate phenolic extract/kg rat/day for 21 days 
and at the end of the study rats were anesthetized with isoflurane and sacrificed by 
intracardiac puncture. After blood collection, rats were perfused with an isotonic solution of 
sodium chloride 0.9% to remove the remaining blood irrigating the tissues, and their livers 
were excised, homogenized and lysed to perform Real-time quantitative PCR. CON values 
were set at 1 and SEC, THY and SEC+THY results are expressed as fold-increase or -
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